SoftBank to invest $900 million in gene sequencing firm Pacific Biosciences

The latest healthcare investment from SoftBank, in the form of convertible debt, will help accelerate the commercialization of Pacific Biosciences’ gene sequencing technology. Last month, Bloomberg News reported that SoftBank had picked up a 6% stake in the company. Pacific Biosciences’ stock has risen more than nine-fold in the last 12 months and has a market value of $7.4 billion.

Leave a Reply